openPR Logo
Press release

Rise in Prevalence of Multiple Sclerosis Anticipated to Drive Global Multiple Sclerosis Drugs Market: Ken Research

01-14-2021 03:12 PM CET | Health & Medicine

Press release from: Ken Research Pvt Ltd

Rise in Prevalence of Multiple Sclerosis Anticipated to Drive

The multiple sclerosis is a nervous system disease that affects the spinal cord and brain. It damages the myelin sheath, which is a term used to exemplify that materials which surrounds & protects human nerve cells. This damage blocks the messages between the brain & body and leads to the symptoms of multiple sclerosis. It affects women more than men. The disease occurs between age group of 20 to 40. It is mainly divided into four types: relapsing-remitting multiple sclerosis, progressive-relapsing multiple sclerosis, secondary-progressive multiple sclerosis and primary-progressive multiple sclerosis. Relapsing-remitting multiple sclerosis is most common form of the disease. Some of the key symptoms of multiple sclerosis include thinking & memory problems, problem in coordination, visual disturbances, and balancing of the body & muscle weakness.

According to study, “Multiple Sclerosis Drugs Market Global Report 2020-30” the key companies operating in the global multiple sclerosis drugs market are Bayer HealthCare, Pfizer, Inc., Biogen, Novartis, Roche, Merck & Co., Inc., GlaxoSmithKline, Acorda Therapeutics Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Actelion Pharmaceuticals (Johnson & Johnson), Betaseron, CinnoVex, Extavia, Rebif, EMD Serono (Merck KGaA), AbbVie, Inc., Tysabr. The key companies are rapidly growing their efforts to focus on innovative product launches to cater to the increasing demands for multiple sclerosis drugs. The multiple sclerosis requires an enduring treatment that increases the overall cost of treating any patient.

In order to offer better & effective treatment, companies are developing drugs precise to the treatment of multiple sclerosis.
Based on drug class, multiple sclerosis drugs market is segmented as immunosuppressants, immunomodulators, interferons and others. Based on route of administration, market is segmented as injection (subcutaneous, intramuscular and intravenous) and oral. In addition, based on distribution channel, market is segmented as retail pharmacy, hospital pharmacy and online pharmacy.

The multiple sclerosis drugs market is driven by rise in prevalence of multiple sclerosis. Apart from this, several other factors for instance genetic & environmental are contributing to the increasing incidence of multiple sclerosis. Prevalence of autoimmune diseases such as type1 diabetes & certain infections, including the infectious mononucleosis also lead to rising risk of multiple sclerosis. With the surging incidence of this health condition, the demand for multiple sclerosis drugs will increase considerably in upcoming years which will contribute to the growth of this market size. However, high cost of drugs to treat multiple sclerosis may impact the market. Moreover, growth in development of novel drugs is a key trend for market.

Based on geography, the North-American region holds major share in global multiple sclerosis drugs market owing to rise in awareness about multiple sclerosis and its treatment in the region. The Asian-Pacific and European regions are estimated to exhibit substantial growth rate due to supportive health reimbursement policies over the forecast period. It is expected that future of the global market will be bright as a result of increase in distribution networks of pharmaceutical companies during the forecast period. The global multiple sclerosis drugs market was valued at US $20.83 billion in 2019 and it is likely to grow at a CAGR of 5.20% and reach US $25.52 billion by 2023.

For More Information, Click on the Link Below:-

Related Reports:-

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India

Ken Research is a Global aggregator and publisher of Market intelligence, equity and economy reports. Ken Research provides business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving over 70% of fortune 500 companies globally, some of top consulting companies and Market leaders seek Ken Research’s intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Prevalence of Multiple Sclerosis Anticipated to Drive Global Multiple Sclerosis Drugs Market: Ken Research here

News-ID: 2225326 • Views: 423

More Releases from Ken Research Pvt Ltd

Global Grease market revenue to reach US$ 7 Bn by 2028: Ken Research
Global Grease Market By Geography The Global Grease market is segmented by geography into North America, Europe, Asia- pacific and LAMEA. The Asia Pacific accounted for the largest market share within the global grease market, accounting major chunk of total market revenue in 2022 as it houses most of the lubricating companies. According to the Indian Brand Equity Foundation (IBEF), a semi-government trust formulated by the department of commerce. Mentioned that an investment
The Australia Crop Protection Industry has grown steadily in the last five years …
The Crop Protection Market in Australia saw a steady growth in the period of 2017-2021, and the market is expected to grow at a robust CAGR in the forecasted period. Australia Crop Protection Market Overview: The Australia Crop Protection Market is currently at the growth stage owing to the technological innovations in the industry, pest pressures, rising use of bio-based crop solutions, rising demand for bio-pesticides and the adoption of herbicide-resistant crops
5 Key Insights on US$ 60 Bn Opportunity in Global Thermoformed Plastics Market: …
Buy Now Driven by the rising consumption of thermoformed plastics material in healthcare and packaging industries, Global Thermoformed Plastics Market is forecasted to Cross US$60 Bn by 2028 says Ken Research Study. Thermoforming is a plastic manufacturing process that applies a vacuum or pressure force to stretch a sheet of heated thermoplastic material over an engineered mold to create a 3-dimensional shape or part. After forming, the shaped part is trimmed and finished
Market Research Subscription Services Encourage You in All Your Requirements: Ke …
During the present trend, the market space is very vivacious in nature. In an endeavor to cope with such continual deviations, market contributors are actively in inevitability of research and consulting studies. The Ken Research as an originator of the market intelligence and wide-fluctuating aggregator, equity and region research reports dispense the business intellect and effective consultative crosswise 300+ vertical underscoring the provocative technologies, emerging business models along the routine

All 5 Releases

More Releases for Multiple

Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)
Multiple Sclerosis Therapeutics Market – Increasing prevalence of multiple scl …
Multiple Sclerosis Therapeutics Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Multiple Sclerosis Therapeutics Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive
Global Multiple Sclerosis Market Size, Global Multiple Sclerosis Market Share, G …
The Global Multiple Sclerosis Market Size is majorly driven by the factors such as rising number of consolidations between the market players for exploring the untapped market opportunity across the world. Request for Sample of This Research Report @ Top Key Player:- Hoffmann-La Roche Ltd. Bayer Healthcare AG Teva Pharmaceuticals GlaxoSmithKline AbbVie Inc. Sonafi Pasteur Pfizer Inc. Merck & Company Novartis AG AB Science Opexa Multiple Sclerosis (MS) is a disease in which the insulating covers of nerves and spinal cord are
Multiple Ion Beam Microscopes Market- Multiple Ion Beam Microscopes Have Huge Ap …
An ion beam is a kind of charged particle beam which consists of ions. With the advancement of nanotechnology new and advanced fabrication techniques are required which helps in production of functional features in much smaller scales. Advanced techniques are being used for applications in material science which uses image surfaces producing different features in a nanoscale. Gas field ion source technology has the capability of combining helium and neon
Smart Antenna Market Report 2018: Segmentation by Type (Switched Beam Smart Ante …
Global Smart Antenna market research report provides company profile for Cobham Antenna Systems(Suffolk, United Kingdom), Intel Corp.( Santa Clara, California, United States), Samsung Electronics CoLtd. ( Seoul, South Korea), ArrayComm LLC ( California, United States), Alcatel-Lucent International Holdings Inc.( Paris, France), Motorola Solutions Inc.( Illinois, the U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017,
Thermoseal Group Multiple Award Winners
For the second year in a row, Thermoseal Group is the winner of the coveted Glass and Glazing Industry’s G-Award for ‘Component Supplier of the Year’ as announced at the prestigious Gala Dinner held at the Hilton on Park Lane Hotel in London on Friday 18 November 2016. This was a great day for Thermoseal Group who were also announced winners at two other awards events held that day